VG

Vadiraj Gunari

Active Director Director DIN 11279691
DIN 11279691 First appointment Sep 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Vadiraj Gunari

Data last updated:

Vadiraj Gunari is a Director at Abdiel (India) Lifesciences Private Limited (since 2025). The company operates in Pharma.

DIN 11279691
Primary Designation Director
Industry Pharma
First Appointment 04 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director04 Sep 20252025Active

Directorship timeline

Open interactive timeline →
Abdiel (India) Lifesciences Private Limited
Premium access

Shareholding and investment profile for Vadiraj Gunari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vadiraj Gunari

Vadiraj Gunari currently holds 1 directorship: Abdiel (India) Lifesciences Private Limited (Director, since 04 Sep 2025).

Vadiraj Gunari was first appointed on 04 Sep 2025 as Director at Abdiel (India) Lifesciences Private Limited.

The current boards of Vadiraj Gunari's companies include Megha Suresh Tikotikar (Abdiel (India) Lifesciences Private Limited), Narayana Bhimarao Gunari (Abdiel (India) Lifesciences Private Limited), Pralhad Bhimarao Gunari (Abdiel (India) Lifesciences Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available